Basic Information
RNALocate ID: RLID:11002544
RNA Symbol: hsa-miR-381-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-381-3p
RNA ID: miRBase:MIMAT0000736
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23382797
Tissue/Cell Line: Brain tissue
Method: Microarray
Description: We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11002543 Exosome Serum 18589210
RLID:11002545 Exosome Plasma 23663360
RLID:11002546 Exosome B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells 25242326
RLID:11002547 Microvesicle Cerebrospinal fluid 24797360
RLID-D:11000125 Exosome Blood|Endothelial cells
RLID-D:11000424 Microvesicle Blood|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-381-3p Oral squamous cell carcinoma MNDR-E-MI-47037
MNDR hsa-miR-381-3p High-grade serous ovarian carcinoma MNDR-E-MI-47038
MNDR hsa-miR-381-3p Ovarian clear cell carcinoma MNDR-E-MI-47039
MNDR hsa-miR-381-3p Uterine corpus endometrial carcinoma MNDR-E-MI-47040
MNDR hsa-miR-381-3p Autism spectrum disorder MNDR-E-MI-47041
MNDR hsa-miR-381-3p Lymphoma MNDR-E-MI-47042
MNDR hsa-miR-381-3p Estrogen-receptor positive breast cancer MNDR-E-MI-47043
MNDR hsa-miR-381-3p Estrogen-receptor negative breast cancer MNDR-E-MI-47044
MNDR hsa-miR-381-3p Progesterone-receptor positive breast cancer MNDR-E-MI-47045
MNDR hsa-miR-381-3p Progesterone-receptor negative breast cancer MNDR-E-MI-47046
MNDR hsa-miR-381-3p Her2-receptor positive breast cancer MNDR-E-MI-47047
MNDR hsa-miR-381-3p Breast cancer luminal MNDR-E-MI-47048
MNDR hsa-miR-381-3p Lupus nephritis MNDR-E-MI-47049
MNDR hsa-miR-381-3p Dermatomyositis MNDR-E-MI-47050
MNDR hsa-miR-381-3p Prostate cancer MNDR-E-MI-47051
MNDR hsa-miR-381-3p Gastric cancer MNDR-E-MI-47052
MNDR hsa-miR-381-3p Alzheimer disease MNDR-E-MI-47053
MNDR hsa-miR-381-3p Bladder cancer MNDR-E-MI-47054
MNDR hsa-miR-381-3p Esophageal carcinoma MNDR-E-MI-47055
MNDR hsa-miR-381-3p Dysautonomia familial MNDR-E-MI-47056
MNDR hsa-miR-381-3p Myotonic dystrophy MNDR-E-MI-47057
MNDR hsa-miR-381-3p Muscular dystrophy duchenne MNDR-E-MI-47058
MNDR hsa-miR-381-3p Huntington disease MNDR-E-MI-47059
MNDR hsa-miR-381-3p Cardiovascular disease MNDR-E-MI-47060
MNDR hsa-miR-381-3p Lung cancer MNDR-E-MI-47061
MNDR hsa-miR-381-3p Fragile x syndrome MNDR-E-MI-47062
MNDR hsa-miR-381-3p Parkinson disease MNDR-E-MI-47063
MNDR hsa-miR-381-3p Major depressive disorder MNDR-E-MI-47064
MNDR hsa-miR-381-3p Basal-like breast cancer MNDR-E-MI-47065
MNDR hsa-miR-381-3p Thyroid cancer MNDR-E-MI-47066
MNDR hsa-miR-381-3p Pituitary neoplasms MNDR-E-MI-47067
MNDR hsa-miR-381-3p Pancreatic cancer MNDR-E-MI-47068
MNDR hsa-miR-381-3p Melanoma MNDR-E-MI-47069
MNDR hsa-miR-381-3p Rectum adenocarcinoma MNDR-E-MI-47070
MNDR hsa-miR-381-3p Nephroblastoma MNDR-E-MI-47071
MNDR hsa-miR-381-3p Colon cancer MNDR-E-MI-47072
MNDR hsa-miR-381-3p Familial ovarian cancer MNDR-E-MI-47073
MNDR hsa-miR-381-3p Acromegaly MNDR-E-MI-47074
MNDR hsa-miR-381-3p Prostate adenocarcinoma MNDR-E-MI-47075
MNDR hsa-miR-381-3p Pulmonary tuberculosis MNDR-E-MI-47076
MNDR hsa-miR-381-3p Carcinoma ductal breast MNDR-E-MI-47077
MNDR hsa-miR-381-3p Glioblastoma MNDR-E-MI-47078
MNDR hsa-miR-381-3p Glioma MNDR-E-MI-47079
MNDR hsa-miR-381-3p Nemaline myopathy MNDR-E-MI-47080
MNDR hsa-miR-381-3p Amyotrophic lateral sclerosis MNDR-E-MI-47081
MNDR hsa-miR-381-3p Osteosarcoma MNDR-E-MI-47082
MNDR hsa-miR-381-3p Liposarcoma MNDR-E-MI-47083
MNDR hsa-miR-381-3p Inclusion body myositis MNDR-E-MI-47084
MNDR hsa-miR-381-3p Breast carcinoma MNDR-E-MI-47085
MNDR hsa-miR-381-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-47086
MNDR hsa-miR-381-3p Uterine cancer MNDR-E-MI-47087
MNDR hsa-miR-381-3p Gastric adenocarcinoma MNDR-E-MI-47088
MNDR hsa-miR-381-3p Cervical squamous cell carcinoma MNDR-E-MI-47089
MNDR hsa-miR-381-3p Bone-invasive pituitary adenoma MNDR-E-MI-47090
MNDR hsa-miR-381-3p Lung squamous cell carcinoma MNDR-E-MI-47091
MNDR hsa-miR-381-3p Non-small cell lung adenocarcinoma MNDR-E-MI-47092
MNDR hsa-miR-381-3p Lung adenocarcinoma MNDR-E-MI-47093
MNDR hsa-miR-381-3p Adrenocortical carcinoma MNDR-E-MI-47094
MNDR hsa-miR-381-3p Thyroid carcinoma MNDR-E-MI-47095
MNDR hsa-miR-381-3p Papillary thyroid carcinoma MNDR-E-MI-47096
MNDR hsa-miR-381-3p Ovarian carcinoma MNDR-E-MI-47097
MNDR hsa-miR-381-3p Bladder urothelial carcinoma MNDR-E-MI-47098
MNDR hsa-miR-381-3p Carcinoma renal cell MNDR-E-MI-47099
MNDR hsa-miR-381-3p Kidney renal papillary cell carcinoma MNDR-E-MI-47100
MNDR hsa-miR-381-3p Renal clear cell carcinoma MNDR-E-MI-47101
MNDR hsa-miR-381-3p Cholangiocarcinoma MNDR-E-MI-47102
MNDR hsa-miR-381-3p Esophageal cancer MNDR-E-MI-47103
MNDR hsa-miR-381-3p Lung small cell carcinoma MNDR-E-MI-47104
MNDR hsa-miR-381-3p Head and neck squamous cell carcinoma MNDR-E-MI-47105
MNDR hsa-miR-381-3p Growth hormone-secreting pituitary adenoma MNDR-E-MI-47106
MNDR hsa-miR-381-3p Breast invasive carcinoma MNDR-E-MI-47107
MNDR hsa-miR-381-3p Hepatocellular carcinoma MNDR-E-MI-47108
MNDR hsa-miR-381-3p Familiar ovarian carcinoma MNDR-E-MI-47109
MNDR hsa-miR-381-3p Rheumatoid arthritis MNDR-E-MI-47110
MNDR hsa-miR-381-3p Barrett's adenocarcinoma MNDR-E-MI-47111
MNDR hsa-miR-381-3p Chronic fatigue syndrome MNDR-E-MI-47112
MNDR hsa-miR-381-3p Tonsil cancer MNDR-E-MI-47113
MNDR hsa-miR-381-3p Psoriasis MNDR-E-MI-47114
MNDR hsa-miR-381-3p Colorectal cancer MNDR-E-MI-47115
MNDR hsa-miR-381-3p Stroke lacunar MNDR-E-MI-47116
MNDR hsa-miR-381-3p Barrett's carcinogenesis MNDR-E-MI-47117
MNDR hsa-miR-381-3p Breast cancer her3+ negative MNDR-E-MI-47118
MNDR hsa-miR-381-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-47119
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ANO1 Homo sapiens RR00082904
TOP